Neonatal Orally Administered Zingerone Attenuates Alcohol-Induced Fatty Liver Disease in Experimental Rat Models

Neonatal Orally Administered Zingerone Attenuates Alcohol-Induced Fatty Liver Disease in Experimental Rat Models

Alcohol intake at different developmental stages can lead to the development of alcohol-induced fatty liver disease (AFLD). Zingerone (ZO) possess hepato-protective properties; thus, when administered neonatally, it could render protection against AFLD. This study aimed to evaluate the potential lon...

Full description

Bibliographic Details
Main Authors: Bernice Asiedu, Busisani Wiseman Lembede, Monica Gomes, Abe Kasonga, Pilani Nkomozepi, Trevor Tapiwa Nyakudya, Eliton Chivandi
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Metabolites
Subjects:
alcohol-induced fatty liver disease
zingerone
peroxisome proliferator activator receptor-alpha (<i>PPAR-α</i>)
sterol regulatory element binding protein 1c (<i>SREBP1c</i>)
macrosteatosis
Online Access:https://www.mdpi.com/2218-1989/13/2/167

Internet

https://www.mdpi.com/2218-1989/13/2/167

Similar Items